Figure: 1 Few Citations of Liquid Biopsy
Figure: 2 Latin America Market Drivers and Restraints
Figure: 3 Latin America Liquid Biopsy Market, 2017-2025
Figure: 4 Latin America Liquid Biopsy Market (by Product Type), 2017 and 2025
Figure: 5 Latin America Liquid Biopsy Market (by Circulating Biomarkers), 2017 and 2025
Figure: 6 Latin America Liquid Biopsy Market (by Clinical Application), 2017-2025
Figure: 7 Latin America Liquid Biopsy Market (by Therapeutic Application), 2017-2025
Figure: 8 Latin America Liquid Biopsy Market (by Country), 2017-2025
Figure: 9 Adoption Rate: Tissue Biopsy vs. Liquid biopsy
Figure: 1.1 Different Types of Biomarkers in Liquid Biopsy
Figure: 1.2 Evolution of Liquid Biopsy with Progress in Molecular Technologies and Biomarker Discovery
Figure: 1.3 Workflow Model of Tissue and Liquid Biopsy
Figure: 1.4 Clinical Applications of Liquid Biopsy
Figure: 1.5 Latin America Liquid Biopsy Market, 2017-2025
Figure: 2.1 Market Dynamics of LATAM Liquid Biopsy Market
Figure: 3.1 Market Share Analysis: Latin America Liquid Biopsy Market, 2016 and 2017
Figure: 3.2 Porter’s Five Forces Analysis
Figure: 3.3 Bargaining Power of Suppliers: Overall Impact, 2014-2025
Figure: 3.4 Bargaining Power of Buyers: Overall Impact, 2014-2025
Figure: 3.5 Threat of New Entrant: Overall Impact, 2014-2025
Figure: 3.6 Threat of Substitute Products: Overall Impact, 2014-2025
Figure: 3.7 Intensity of Competitive Rivalry: Overall Impact, 2014-2025
Figure: 4.1 Latin America Liquid Biopsy Market (by Circulating Biomarkers)
Figure: 4.2 Liquid Biopsy Market (by Product Type), 2017-2025
Figure: 4.3 Latin America Liquid Biopsy Market (by Tests/Services), 2017-2025
Figure: 4.4 Latin America Liquid Biopsy Market (by Kits and Consumables), 2017-2025
Figure: 4.5 Latin America Liquid Biopsy Market (by Instruments), 2017-2025
Figure: 5.1 Different Circulating Biomarkers
Figure: 5.2 Latin America Liquid Biopsy Market (by Circulating Biomarkers)
Figure: 5.3 Latin America Liquid Biopsy Market (by Circulating Biomarker), 2017 and 2025
Figure: 5.4 Latin America Liquid Biopsy Market (by ctDNA), 2017-2025
Figure: 5.5 CTCs vs. ctDNA Analysis
Figure: 5.6 Latin America Liquid Biopsy Market (by CTCs), 2017-2025
Figure: 5.7 Latin America Liquid Biopsy Market (by cfDNA), 2017-2025
Figure: 5.8 Latin America Liquid Biopsy Market (by Extracellular Vesicles and Others), 2017-2025
Figure: 6.1 Latin America Liquid Biopsy Market (by Clinical Applications)
Figure: 6.2 Liquid Biopsy Market (by Clinical Application), 2017-2025
Figure: 6.3 Latin America Liquid Biopsy Market (by Treatment Monitoring), 2017-2025
Figure: 6.4 Latin America Liquid Biopsy Market (by Prognosis and Recurrence Monitoring), 2017-2025
Figure: 6.5 Latin America Liquid Biopsy Market (by Treatment Selection), 2017-2025
Figure: 6.6 Latin America Liquid Biopsy Market (by Diagnosis and Screening), 2017-2025
Figure: 7.1 Latin America Liquid Biopsy Market (by Therapeutic Applications)
Figure: 7.2 Latin America Liquid Biopsy Market (by Therapeutic Applications), 2017-2025
Figure: 7.3 Types of Breast Cancer
Figure: 7.4 Latin America Liquid Biopsy Market (by Breast Cancer), 2017-2025
Figure: 7.5 Types of Lung Cancer
Figure: 7.6 Latin America Liquid Biopsy Market (by Lung Cancer), 2017-2025
Figure: 7.7 Latin America Liquid Biopsy Market (by Prostate Cancer), 2017-2025
Figure: 7.8 Latin America Liquid Biopsy Market (by Colorectal Cancer), 2017-2025
Figure: 7.9 Latin America Liquid Biopsy Market (by Melanoma Cancer), 2017-2025
Figure: 7.10 Latin America Liquid Biopsy Market (by Other Types of Cancer), 2017-2025
Figure: 7.11 Latin America Liquid Biopsy Market (by Non-Oncology), 2017-2025
Figure: 8.1 Latin America Liquid Biopsy Market, 2017-2025
Figure: 8.2 Latin America Liquid Biopsy Market (by Country), 2017-2025
Figure: 8.3 Brazil Liquid Biopsy Market, 2017-2025
Figure: 8.4 Brazil Liquid Biopsy Market (by Therapeutic Application), 2017-2025
Figure: 8.5 Mexico Liquid Biopsy Market, 2017-2025
Figure: 8.6 Mexico: Liquid Biopsy Market (by Therapeutic Application), 2017-2025
Figure: 8.7 Argentina Liquid Biopsy Market, 2017-2025
Figure: 8.8 Argentina: Liquid Biopsy Market (by Therapeutic Application), 2017-2025
Figure: 8.9 Chile Liquid Biopsy Market, 2017-2025
Figure: 8.10 Chile: Liquid Biopsy Market (by Therapeutic Application), 2017-2025
Figure: 8.11 Colombia Liquid Biopsy Market, 2017-2025
Figure: 8.12 Colombia: Liquid Biopsy Market (by Therapeutic Application), 2017-2025
Figure: 8.13 Rest-of-Latin America Liquid Biopsy Market, 2017-2025
Figure: 9.1 Shares of Key Company Profiles
Figure: 9.2 Product Offerings
Figure: 9.3 Biocept, Inc.: Overall Financials, 2015-2017
Figure: 9.4 Biocept, Inc.: R&D Expense, 2015-2017
Figure: 9.5 Biocept, Inc.: SWOT Analysis
Figure: 9.6 Bio-Rad Laboratories, Inc.: Product Offerings
Figure: 9.7 Bio-Rad laboratories, Inc.: Overall Financials, 2015-2017
Figure: 9.8 Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2015-2017
Figure: 9.9 Bio-Rad Laboratories, Inc.: Revenue (by Region), 2015-2017
Figure: 9.10 Bio-Rad Laboratories, Inc.: R&D Expense, 2015-2017
Figure: 9.11 Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure: 9.12 Contextual Genomics Inc.: SWOT Analysis
Figure: 9.13 Epic Sciences, Inc.: Product Offerings
Figure: 9.14 Epic Sciences, Inc.: SWOT Analysis
Figure: 9.15 F. Hoffmann-La Roche AG: Product Offerings
Figure: 9.16 F. Hoffmann-La Roche AG: Overall Financials, 2015-2017
Figure: 9.17 F. Hoffmann-La Roche AG: Revenue (by Business Segment), 2015-2017
Figure: 9.18 F. Hoffmann-La Roche Ltd.: Revenue (by Diagnostics Sub-division), 2015-2017
Figure: 9.19 F. Hoffmann-La Roche AG: Revenue (by Region), 2015-2017
Figure: 9.20 F. Hoffmann-La Roche AG: R&D Expense, 2015-2017
Figure: 9.21 F. Hoffmann-La Roche AG: SWOT Analysis
Figure: 9.22 Guardant Health, Inc.: Product Offerings
Figure: 9.23 Guardant Health, Inc.: SWOT Analysis
Figure: 9.24 Illumina, Inc.: Product Offerings
Figure: 9.25 Illumina, Inc.: Overall Financials, 2015-2017
Figure: 9.26 Illumina, Inc.: Revenue (by Business Segment), 2015-2017
Figure: 9.27 Illumina, Inc.: Revenue (by Region), 2015-2017
Figure: 9.28 Illumina, Inc.: R&D Expense, 2015-2017
Figure: 9.29 Illumina, Inc.: SWOT Analysis
Figure: 9.30 MDxHealth, Inc.: Product Offerings
Figure: 9.31 MDxHealth, Inc.: Overall Financials, 2015-2017
Figure: 9.32 MDxHealth, Inc.: R&D Expanse, 2015-2017
Figure: 9.33 MDxHealth, Inc.: SWOT Analysis
Figure: 9.34 Menarini Silicon Biosystems, Inc.: Product Offerings
Figure: 9.35 Menarini Silicon Biosystems, Inc.: SWOT Analysis
Figure: 9.36 Metacell s.r.o: SWOT Analysis
Figure: 9.37 Myriad Genetics, Inc.: Product Offerings
Figure: 9.38 Myriad Genetics, Inc.: Overall Financials, 2015-2017
Figure: 9.39 Myriad Genetics, Inc.: Revenue (by Business Segment), 2015-2017
Figure: 9.40 Myriad Genetics, Inc.: Revenue (by Region), 2015-2017
Figure: 9.41 Myriad Genetics, Inc.: R&D Expense, 2015-2017
Figure: 9.42 Myriad Genetics, Inc.: SWOT Analysis
Figure: 9.43 NeoGenomics Laboratories, Inc.: Product Offerings
Figure: 9.44 NeoGenomics Laboratories, Inc.: Overall Financials, 2015-2017
Figure: 9.45 NeoGenomics Laboratories, Inc.: Revenue (by Business Segment), 2015-2017
Figure: 9.46 NeoGenomics Laboratories, Inc.: R&D Expense, 2015-2017
Figure: 9.47 NeoGenomics Laboratories, Inc.: SWOT Analysis
Figure: 9.48 Qiagen N.V.: Product Offerings
Figure: 9.49 Qiagen N.V.: Overall Financials, 2015-2017
Figure: 9.50 Qiagen N.V.: Revenue (by Business Segment), 2015-2017
Figure: 9.51 Qiagen N.V.: Revenue (by Region), 2015-2017
Figure: 9.52 Qiagen N.V.: R&D Expense, 2015-2017
Figure: 9.53 Qiagen N.V.: SWOT Analysis
Figure: 9.54 Sysmex Inostics GmbH: Product Offerings
Figure: 9.55 Sysmex Inostics GmbH: SWOT Analysis
Figure: 9.56 Thermo Fisher Scientific Inc.: Product Offerings
Figure: 9.57 Thermo Fisher Scientific Inc.: Overall Financials, 2015-2017
Figure: 9.58 Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2015-2017
Figure: 9.59 Thermo Fisher Scientific Inc.: Revenue (by Region), 2015-2017
Figure: 9.60 Thermo Fisher Scientific Inc.: R&D Expense, 2015-2017
Figure: 9.61 Thermo Fisher Scientific Inc.: SWOT Analysis
Figure: 10.1 Latin America Liquid Biopsy: Market Segmentation
Figure: 10.2 Latin America Liquid Biopsy Market Segmentation
Figure: 10.3 Primary Research
Figure: 10.4 Secondary Research
Figure: 10.5 Data Triangulation
Figure: 10.6 Top-down Approach (Segment-wise Analysis)
Figure: 10.7 Bottom-up Approach (Segment-wise Analysis)
Figure: 10.8 Assumptions and Limitations
Figure: 10.9 Considered Factors for Data Prediction and Modelling